ADIPOQ and metabolic syndrome: Adiponectin is reported to be associated with disease activity of patients with rheumatoid arthritis [16,17], and low adiponectin concentrations are associated with metabolic syndrome, obesity-linked insulin resistance and atherosclerosis [8,18,19].